 |
| Market Alert: ADMD on High Alert Up 23% |
|
 Hot Stock to Watch |
Company: Advanced Medical Isotope Corporation (OTCQB: ADMD)
|
Last:
Price: 0.063
Change (%): + 0.012 (23.53)
Volume: 229,500 |
 |
James C. Katzaroff, CEO & Founder of Advanced Medical Isotope Corporation, is Featured in a New Audio Interview at SmallCapVoice.com
AUSTIN, Texas, Nov. 6, 2013 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. announced today that a new audio interview with Advanced Medical Isotope Corporation (OTCQB:ADMD) is now available. The interview can be heard at http://smallcapvoice.com/blog/11-6-13-smallcapvoice-interview-with-advanced-medical-isotope-corp-admd
James C. Katzaroff, CEO & Founder of Advanced Medical Isotope Corporation, called in to SmallCapVoice.com to discuss the recent announcement that ADMD has filed pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 RadioGel(TM) patented brachytherapy cancer product.
In the interview AMIC CEO Jim Katzaroff commented: “We believe with our Yttrium-90 RadioGel(TM) patented brachytherapy there’s a shorter penetration distance, and a shorter half life for the isotope. This allows it to attack the tumor, but cause less collateral damage to the healthy tissues. It also uses a biodegradable carrier with FDA approved components. This means there is no metal or glass left inside the patient. The introduction of our Yttrium-90 products will introduce a new era for AMIC.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
